At a glance
ClinicalIndex Comparison RecordN/ACompleted· 161 enrolled
Drug / intervention
Procainamidedrug
Likely dose
Procainamide 10mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ST-segment Elevation With Procainamide as an ECG Endophenotype of AF
In Brief
A clinical study evaluating Procainamide for Atrial Fibrillation. Completed, enrolled 161 participants across 1 site.
Detailed Summary
The purpose of this study is to look for a similarity in people's genes that may help understand which people could benefit from certain drugs for the treatment of atrial fibrillation (AF).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesUnited States
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2010
Enrollment StartNov 2010
Primary CompletionJun 2015
TodayJul 2026
First PostedSep 20, 2010
Enrollment StartNov 1, 2010
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 15.8 years ago
Interventions
Procainamidedrug
One time intravenous infusion of Procainamide administered over 30 minutes. Dosage is calculated as 10mg/kg based on subject's ideal body weight.